Idarubicin Hydrochloride Clinical Trials

4 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Also known as: IMI-30, Idarubicin hydrochloride injection, Idarubicine, Zavedos

Pipeline

Early 1: 1Phase 2: 3

Top Sponsors

Children's Hospital of Soochow University2
St. Jude Children's Research Hospital1
Baylor College of Medicine1

Indications

Cancer4
Acute Myeloid Leukemia3
AML, Childhood2
Pediatric AML1
C-KIT Mutation1

Other2 trials

Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML

Phase 2

Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

Phase 2

Madera, California1 trial

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Valley Children's Hospital

Phase 2

Houston, Texas1 trial

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Texas Children's Cancer and Hematology Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.